The first two Medical Objectives (MOs) of the project are to better understand frailty and its relation to co-morbidities (MO1) and develop quantitative and qualitative measures to define frailty (MO2).
FrailSafe Objectives are divided into Medical (MOs) and Technological Objectives (TOs). Medical Objectives are related to the identification of quantitative and qualitative measures of frailty and the associated co-morbidities. The MOs of the project are summarized in the following points:
The first two Medical Objectives (MOs) of the project are to better understand frailty and its relation to co-morbidities (MO1) and develop quantitative and qualitative measures to define frailty (MO2).
The third Medical Objective of the project concerns the use of measures developed in order to predict the short and long-term outcome (MO3).
The fourth Medical Objective of the project is to develop real life tools for the assessment of physiological reserve and external challenges (MO4).
The fifth Medical Objective of the project is to provide a model sensitive to change in order that will facilitate the testing of pharmaceutical and non-pharmaceutical interventions, which will be designed to delay, arrest or even reverse the transition to frailty, can be tested (MO5).
The sixth Medical Objective of the project is to create “prevent-frailty” evidence based recommendations for older people regarding activities of daily living, lifestyle, nutrition, etc. to strengthen the motor, cognitive, and other “anti-frailty” activities through the delivery of personalised treatment programmes, games, monitoring alerts, guidance and education and estimate the influence of these interventions (MO6).
The seventh Medical Objective of the project is to achieve all through a safe, unobtrusive and acceptable system for the ageing population while reducing the cost of health care systems (MO7)